Cardiovascular Systems CEO Steps Down

Cardiovascular Systems has announced that David Martin, the company’s president and CEO, will be stepping down to make his cancer treatment a top priority.

In the meantime, Chairman Scott Ward will remain as interim president and CEO as the company searches for Martin’s successor.

“Dave has guided this company on an extraordinary journey, developing orbital atherectomy from an early stage innovation to a market-leading product that has saved lives and improved the quality of life for thousands of patients,” said Ward. “On behalf of our employees and board of directors, we thank Dave for his many contributions to our company and we wish him well with his continuing treatment.”

Martin, who announced his diagnosis last September, transformed the startup into a public company, with fiscal year 2015 revenues in excess of $180 million, according to the statement. — Anisa Jibrell